west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "QIAN Jing" 2 results
  • Effect of micro RNA-335-5p regulating bone morphogenetic protein 2 on osteogenic differentiation of human bone marrow mesenchymal stem cells

    ObjectiveTo investigate the effect of micro RNA (miR)-335-5p regulating bone morphogenetic protein 2 (BMP-2) on the osteogenic differentiation of human bone marrow mesenchymal stem cells (hBMSCs).MethodshBMSCs were cultured in vitro and randomly divided into control group (group A), miR-335-5p mimics group (group B), miR-335-5p mimics negative control group (group C), miR-335-5p inhibitor group (group D), and miR-335-5p inhibitor negative control group (group E). After grouping treatment and induction of osteogenic differentiation, the osteogenic differentiation of cells in each group was detected by alkaline phosphatase (ALP) and alizarin red staining; the expressions of miR-335-5p and BMP-2, Runt-related transcription factor 2 (Runx2), osteopontin (OPN), and osteocalcin (OCN) mRNAs were detected by real-time fluorescence quantitative PCR analysis; the expressions of Runx2, OPN, OCN, and BMP-2 proteins were detected by Western blot.ResultsCompared with group A, the relative proportion of ALP positive cells and the relative content of mineralized nodules, the relative expressions of BMP-2, miR-335-5p, OPN, OCN, Runx2 mRNAs, the relative expressions of Runx2, OPN, OCN, and BMP-2 proteins in group B were significantly increased (P<0.05); the above indexes in group D were significantly decreased (P<0.05); the above indexes between groups C, E and group A were not significantly different (P>0.05).ConclusionmiR-335-5p can up-regulate BMP-2 expression and promote osteogenic differentiation of hBMSCs.

    Release date:2020-07-07 07:58 Export PDF Favorites Scan
  • Feasibility of laparoscopic hepatectomy of malignant liver tumors under the day surgery management model: based on concept of enhanced recovery after surgery

    ObjectiveTo explore the feasibility of laparoscopic hepatectomy of malignant liver tumors under the day surgery management model based on the concept of enhanced recovery after surgery (ERAS). MethodsThree patients who underwent same-day laparoscopic resection of malignant liver tumors in the Department of Hepatobiliary Surgery of the First Affiliated Hospital of Guangxi Medical University from June to November 2022 were retrospectively collected. The clinical application effects of this model were comprehensively evaluated. ResultsAll 3 patients (cases 1–3) successfully completed complete laparoscopic anatomical partial liver resection, with operation times of 155, 183, and 201 min, respectively, and intraoperative blood loss of all <100 mL (20, 100, and 50 mL, respectively). Postoperative pathology confirmed that cases 1 and 2 were hepatocellular carcinoma, and case 3 was colorectal adenocarcinoma with liver metastasis, and the resection margins all met the R0 standard. All patients resumed oral feeding 6 h after surgery and were able to get out of bed within 8 h after surgery. All 3 patients were discharged within 24 h after surgery. The hospitalization cost of the three patients was (22 602.0±3 400.0) yuan. All patients were followed up for more than 24 months and maintained a tumor-free survival state, without tumor recurrence and metastasis. ConclusionThe results of this limited cases suggest that same-day laparoscopic liver resection is initially feasible and safe for strictly selected patients with liver malignancies combined with a standardized ERAS management pathway.

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content